Literature DB >> 14650147

[Thoracic high resolution CT findings of 100 SARS patients in convalescent period].

Zheng-yu Jin1, Hui You, Wei-hong Zhang, Yun Wang, Ji-xiang Liang, Wen-bin Mu, Min Peng, Yi Ma, Bai-qiang Cai, Zhong Wang, Wen-bing Xu, Tai-sheng Li, Wei Cui.   

Abstract

OBJECTIVE: To study thoracic high resolution CT findings of severe acute respiratory syndrome (SARS) patients in convalescent period and the relationship between the features with laboratory and pulmonary function results.
METHODS: All the 100 SARS patients who had been discharged from hospital for about 2 months underwent thoracic high resolution CT examinations. Among them, 65 also had laboratory results and 91 underwent examinations of pulmonary function.
RESULTS: Forty-nine SARS patients (49.0%, 49/100) in convalescent period still had abnormal findings in CT examination. And ground-glass opacification (95.9%, 47/49) and reticular opacification (59.2%, 29/49) were common. There was no significant difference in the level of lymphocytes and CD4 cells among groups divided according to severity of CT findings (P > 0.01). Diffusing capacity for carbon monoxide (DLco%) of level 2 and 3 were statistically lower than that of level 0 (P < 0.01).
CONCLUSIONS: The features of CT findings of SARS patients in convalescent period are not the same as those of patients in period of apparent manifestation. The high resolution CT can reflect pulmonary diffusing function to some degree.

Entities:  

Mesh:

Year:  2003        PMID: 14650147

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  5 in total

Review 1.  Pulmonary function test and computed tomography features during follow-up after SARS, MERS and COVID-19: a systematic review and meta-analysis.

Authors:  Christopher C Huntley; Ketan Patel; Shahnoor-E-Salam Bil Bushra; Farah Mobeen; Michael N Armitage; Anita Pye; Chloe B Knight; Alyaa Mostafa; Marie Kershaw; Aishah Z Mughal; Emily McKemey; Alice M Turner; P Sherwood Burge; Gareth I Walters
Journal:  ERJ Open Res       Date:  2022-05-30

2.  Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case-Control Study.

Authors:  Li Li; Chun-Yan Gou; Xue-Mei Li; Wen-Yan Song; Xiao-Jun Wang; Hong-Ying Li; Hong-Yan Li; Xiu-Hui Li
Journal:  Chin J Integr Med       Date:  2021-02-03       Impact factor: 1.978

3.  Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks.

Authors:  Kajal Patel; Sofia Straudi; Ng Yee Sien; Nora Fayed; John L Melvin; Manoj Sivan
Journal:  Int J Environ Res Public Health       Date:  2020-09-05       Impact factor: 3.390

Review 4.  Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.

Authors:  Krishna Murthy P; Karthikeyan Sivashanmugam; Mahesh Kandasamy; Rajasekaran Subbiah; Vilwanathan Ravikumar
Journal:  Life Sci       Date:  2020-12-11       Impact factor: 6.780

5.  Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis: a systematic review and meta-analysis.

Authors:  Laura Fabbri; Samuel Moss; Fasihul A Khan; Wenjie Chi; Jun Xia; Karen Robinson; Alan Robert Smyth; Gisli Jenkins; Iain Stewart
Journal:  Thorax       Date:  2022-03-25       Impact factor: 9.139

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.